Newsroom | 98824 results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named Among Top 100 of America’s Best Companies by TIME...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, refe...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...

TORONTO--(BUSINESS WIRE)--GH Power Inc. and Matinas BioPharma Holdings, Inc enter into Business Combination Agreement....

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (« MindWalk » ou la « Société ») (NASDAQ : HYFT), une entreprise spécialisée dans l’IA bio-native, a annoncé aujourd’hui qu’elle publierait ses résultats financiers pour le quatrième trimestre et l’ensemble de l’exercice 2026, et qu’elle tiendrait une conférence téléphonique le mercredi 22 juillet 2026, à 17 h, heure de l’Est. Les résultats financiers seront publiés dans un communiqué de presse avant la conférence téléphonique, qui compren...

WHITE BEAR LAKE, Minn.--(BUSINESS WIRE)--A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for 8.4% Sodium Bicarbonate Injection, USP 50 mEq/ 50 mL vials for intravenous use. Sodium Bicarbonate for Injection, USP is indicated as an alkalinizing agent to correct severe metabolic acidosis. The product has intermittently appeared on the FDA Drug shortages l...

DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery and infusion care solutions, announced today that its Targeted Drug Delivery division has been recognized as a 2025 Pioneer in URAC's Leaders in Performance Measurement (LPM) recognition program. This honor is awarded to URAC-accredited organizations who demonstrate leadership in measuring and improving the quality of patient care through performance measurement. The recognition follows URAC's annual review of...

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for which they may be eligible, today announced a new partnership with Sequence Me Now (SMN), a nonprofit patient advocacy organization dedicated to helping cancer patients access genomic sequencing and personalized medicine. Through the partnership, Massive Bio is featured on the "Find a Trial" page of Sequence Me Now's website, the fourth step...

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today announced it received top rankings in independent McKinsey research, was named an MM+M Power Partner, and had three executives named to the PM360 ELITE 100. In independent market research conducted by McKinsey & Company, ConnectiveRx earned the highest affordability Net Promoter Score (NPS) and was also recognized as having...